These success, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two guidance the thought of targeting ACKR3 as a singular approach to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked disorders.These outcomes suggest that conolidine is re